Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Baggerly

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Clinical Chemistry|March 3, 2011
What information should be required to support clinical "omics" publications?Keith A Baggerly, Kevin R Coombes
Nature Medicine|November 8, 2007
Microarrays: retracing stepsKevin R Coombes, Jing Wang, Keith A Baggerly
British Journal of Haematology|November 27, 2018
Refining statistics clarifies leukaemic stem cell genomicsShelley M Herbrich, Keith A Baggerly, Marina Konopleva
Biometrics|November 7, 2003
Bayesian shrinkage estimation of the relative abundance of mRNA transcripts using SAGEJeffrey S Morris, Keith A Baggerly, Kevin R Coombes
Bioinformatics (Oxford, England)|January 31, 2004
Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experimentsKeith A Baggerly, Jeffrey S Morris, Kevin R Coombes
Cancer Informatics|May 3, 2012
Surface Adjustment of Reverse Phase Protein Arrays using Positive Control SpotsE Shannon Neeley, Keith A Baggerly, Steven M Kornblau
Cancer Informatics|March 24, 2009
Bias, randomization, and ovarian proteomic data: a reply to "producers and consumers"Keith A Baggerly, Kevin R Coombes, Jeffrey S Morris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancerKeith A Baggerly, Kevin R Coombes, E Shannon Neeley
Proteome Science|January 27, 2012
Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional culturesVictor A Levin, Sonali Panchabhai, Li Shen, et al.
Molecular Imaging and Biology|August 14, 2012
Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopyMadhuri Sankaranarayanapillai, Nianxiang Zhang, Keith A Baggerly, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Clinical Chemistry|March 3, 2011
What information should be required to support clinical "omics" publications?Keith A Baggerly, Kevin R Coombes
Nature Medicine|November 8, 2007
Microarrays: retracing stepsKevin R Coombes, Jing Wang, Keith A Baggerly
British Journal of Haematology|November 27, 2018
Refining statistics clarifies leukaemic stem cell genomicsShelley M Herbrich, Keith A Baggerly, Marina Konopleva
Biometrics|November 7, 2003
Bayesian shrinkage estimation of the relative abundance of mRNA transcripts using SAGEJeffrey S Morris, Keith A Baggerly, Kevin R Coombes
Bioinformatics (Oxford, England)|January 31, 2004
Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experimentsKeith A Baggerly, Jeffrey S Morris, Kevin R Coombes
Cancer Informatics|May 3, 2012
Surface Adjustment of Reverse Phase Protein Arrays using Positive Control SpotsE Shannon Neeley, Keith A Baggerly, Steven M Kornblau
Cancer Informatics|March 24, 2009
Bias, randomization, and ovarian proteomic data: a reply to "producers and consumers"Keith A Baggerly, Kevin R Coombes, Jeffrey S Morris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancerKeith A Baggerly, Kevin R Coombes, E Shannon Neeley
Proteome Science|January 27, 2012
Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional culturesVictor A Levin, Sonali Panchabhai, Li Shen, et al.
Molecular Imaging and Biology|August 14, 2012
Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopyMadhuri Sankaranarayanapillai, Nianxiang Zhang, Keith A Baggerly, et al.
Pageof 10